Evidence map›Paper›PMID 32942816›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].

M L Zhang, W S Chen, B Han

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05399732 (A Randomized, Case Controlled Clinical Trial Evaluating the Efficiency and Safety of Luspatercept Plus Cyclosporine Versus Cyclosporine in Newly Diagnosed Transfusion Independent Non-severe Aplastic Anemia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05399732 phase2completednot on this mapstarted 2022, after this paper: background citation

A Randomized, Case Controlled Clinical Trial Evaluating the Efficiency and Safety of Luspatercept Plus Cyclosporine Versus Cyclosporine in Newly Diagnosed Transfusion Independent Non-severe Aplastic Anemia (NSAA).

TypeinterventionalSponsorBing HanRan2022 to 2025Enrolled58ConditionsAplastic AnemiaArmsLuspatercept, Cyclosporine
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M L ZhangDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences, Beijing 100730, China.
W S ChenDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences, Beijing 100730, China.
B HanDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences, Beijing 100730, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CN

Funding

Chinese Academy of Medical Sciences (CAMS) Innovation fund for Medical Sciences 2016-I2M-3-004Natural Science Foundation of Beijing 7192168Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2019XK320047
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, AplasticAdolescentAdultAgedAged, 80 and overCyclosporineFemaleHumansMaleMiddle AgedPlatelet CountRecombinant ProteinsRetrospective StudiesThrombopoietinTreatment OutcomeYoung AdultCyclosporineRecombinant ProteinsThrombopoietinAdverse effectsAplastic anemiaCyclosporin ARecombined human thrombopoietinTreatment outcome

Identifiers

PMID32942816
PMCPMC7525171
OpenAlexW3087659375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.